Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06315023 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry)

Study acronym: PTAB1
StatusEnrolling by Invitation
PhaseNot specified
SponsorEndologix
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Enrolling by Invitation
    • Site details revised at 10 of 10 sites
    v4
  2. Trial status: Enrolling by Invitation to Recruiting
    • Study sites: 1 to 10
    v3
  3. Primary endpoints revised (2)
    • Study site revised
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Endologix
9 trials monitored
See 1 trial at risk
The purpose of this post-market surveillance study will be to evaluate the real-world use of the DETOUR System in treated patients with symptomatic femoropopliteal lesions from 200 mm to 460 mm in length with chronic total occlusions (100 mm to 425 mm) or diffuse stenosis \> 70% who may be considered suboptimal candidates for surgical or alternative endovascular treatments.
Trial Details
NCT Number NCT06315023
Lead Sponsor Endologix
Collaborators: Fivos, Massachusetts General Hospital, Society for Vascular Surgery Patient Safety Organization
Conditions
(from sponsor)		 Peripheral Arterial Disease, Symptomatic Femoropopliteal Lesions
Related terms Peripheral Arterial Disease
Enrollment 450 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov